​

Hinge Health Stock (NYSE:HNGE)

ForecastRevenueOwnershipFinancialsChartTranscripts
Hinge Health by TradingView

Previous Close

$62.06

52W Range

$30.08 - $66.74

50D Avg

$50.00

200D Avg

$47.57

Market Cap

$5.01B

Avg Vol (3M)

$1.32M

Beta

1.99

Div Yield

-

HNGE Company Profile

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,514

IPO Date

May 22, 2025

Website

HNGE Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25
Reportable Segment$587.86M

Fiscal year ends in Dec 25 | Currency in USD

HNGE Financial Summary

Dec 25Dec 24Dec 23
Revenue$587.86M$390.40M$292.73M
Operating Income$-546.37M$-24.43M$-130.51M
Net Income$-528.26M$-11.93M$-108.14M
EBITDA$-541.24M$-5.31M$-102.92M
Basic EPS$-5.36$-0.15$-1.39
Diluted EPS$-5.19$-0.15$-1.39

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q1 26May 05, 26 | 12:00 AM
Q4 25Feb 10, 26 | 12:00 AM
Q3 25Nov 04, 25 | 4:30 PM

Peer Comparison

TickerCompany
VKTXViking Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
OSCROscar Health, Inc.
PRAXPraxis Precision Medicines, Inc.
DYNDyne Therapeutics, Inc.
WGSGeneDx Holdings Corp.
AKROAkero Therapeutics, Inc.
IMVTImmunovant, Inc.
LNTHLantheus Holdings, Inc.